Skip to main content

Two medicines, side by side

Cefoxitin vs cefazolin

Cefoxitin and cefazolin are both labeled for urinary tract infections. Drugs@FDA records approvals of cefoxitin since 1978 and of cefazolin since 1973. How each works, in its label's words: Cefoxitin, “Mechanism of Action Cefoxitin is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.”; Cefazolin, “Mechanism of Action Cefazolin is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.”

Check it at the source: the cefoxitin FDA label on DailyMed (effective April 11, 2024); the cefazolin FDA label on DailyMed (effective May 14, 2026).

Highlights of the cefoxitin record

Cefoxitin (Mefoxin) · label of April 11, 2024

Used for

From the label: indications

Treatment Cefoxitin for Injection, USP is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. […]

On the market

Earliest approval on file
October 18, 1978
Generic labelers
5 labelers
Pharmacy cost
Not in the survey

Supply and safety

Shortage
No current entry
Recalls
1

Highlights of the cefazolin record

Cefazolin (Ancef) · label of May 14, 2026

Used for

From the label: indications

Cefazolin for Injection, USP is indicated in the treatment of the following serious infections due to susceptible organisms: Respiratory Tract Infections: Due to S. pneumoniae, Klebsiella species, H. influenzae, S. aureus (penicillin-sensitive and penicillin-resistant), and group A beta-hemolytic streptococci. […]

On the market

Earliest approval on file
October 4, 1973
Generic labelers
15 labelers
Pharmacy cost
$1.07 per vial

Supply and safety

Shortage
No current entry
Recalls
10

Source: FDA drug labels via openFDA (Cefoxitin label of April 11, 2024, Cefazolin label of May 14, 2026); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)

How do cefoxitin and cefazolin differ on the record?

How each works, in its label's words: Cefoxitin, “Mechanism of Action Cefoxitin is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.”; Cefazolin, “Mechanism of Action Cefazolin is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.”

Both are in FDA's class cephalosporin antibacterials.

Half-life, in each label's words: Cefoxitin, “The half-life after an intravenous dose is 41 to 59 minutes.”; Cefazolin, “The serum half-life for Cefazolin for Injection is approximately 1.8 hours following IV administration and …”

Generics: cefoxitin since 1987; cefazolin since 1973 (Drugs@FDA).

CefoxitinCefazolin
Labeled forBacterial infections, Urinary tract infectionsUrinary tract infections
Pharmacologic classCephalosporin AntibacterialCephalosporin Antibacterial
How it works (label)Mechanism of Action Cefoxitin is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.Mechanism of Action Cefazolin is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis.
Half-life (label)The half-life after an intravenous dose is 41 to 59 minutes.The serum half-life for Cefazolin for Injection is approximately 1.8 hours following IV administration and approximately 2 hours following IM administration.
Earliest approval on file (Drugs@FDA)October 18, 1978October 4, 1973
First generic approvedJanuary 8, 1987November 2, 1973
Generic labelers (NDC)5 labelers15 labelers
Pharmacy cost (NADAC, each one's most listed form; strengths differ)n/a$1.07 per vial (Cefazolin 1 g vial)
12-month price changen/a+10%
Boxed warningNoNo
Shortage nowNo current entryNo current entry
Recalls recorded110
FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used)1,37311,982
DEA schedulenonenone

Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)

What next?

Alternatives to cefoxitin
every medicine labeled for the same conditions